跳至主要内容
临床试验/NCT06104098
NCT06104098已完成不适用

A User Study With Vernivia® for Bacterial Vaginosis (USV01) Evaluation of User-friendliness, Measure Time From the Start of Treatment to Symptom Relief and the Clarity of Instructional Material

Pharmiva AB14 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Pharmiva AB
入组人数
76
试验地点
14
主要终点
Evaluate symptom relief during treatment with Vernivia®.

研究概览

简要总结

This is an open user study to evaluate D005 vagnial mousse with regards to user-friendliness, and measure time from start of treatment to symptom relief and measure the clarity of instructional material.

The study will be conducted at seven sites in Sweden, the study population will consist of up to 100 female subjects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 49 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 16 - 49 years Informed consent to take part in the study Bacterial vaginosis (based on self-assessment or diagnosed by a doctor or midwife) Access to a smartphone

排除标准

  • Symptoms of vaginal candida infection and/or Pregnancy

结局指标

主要结局

Evaluate symptom relief during treatment with Vernivia®.

时间窗: 1-7 days

Evaluation of number of days from start of treatment until symptom relief

次要结局

  • Net Promotor Score regarding user-friendliness(1-7 days)
  • Clarity of the IFU (Instructions For Use)(1-7 days)
  • Clarity of instructional video(1-7 days)
  • Self-reported grading of malodorous discharge (0-3)(1-7 days)

研究者

发起方
Pharmiva AB
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验

A User Study With Vernivia® for Bacterial Vaginosis. | 临床试验